RxDoctor Payments Data

Christopher Pellegrino, MD

Plastic Surgery · Salisbury, MDNPI 1902843105

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2019 at $609 and has fallen 92.2% since, to $48 in 2025. That places this record below the midpoint for plastic surgery clinicians in MD, where the typical reported total is $1,838.

$1,925in general payments, 2019–2025

Across 91 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$589
  • Galderma Laboratories, L.p.$327
  • Mentor Worldwide LLC$237
  • Sientra, Inc.$221
  • Sun Pharmaceutical Industries Inc.$109
  • Cook Medical LLC$95
  • plus $348 from 11 others

What the payments were for

  • Food & beverage$1,925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,925 in reported general payments places this provider in the 50th percentile of 105 plastic surgery providers in Maryland.

See all plastic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$82,323
Medicare patients
127
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin68$650
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$80
Alprazolam14$15

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →